Symbol not found

:IQT 00:00AM GMT

0.00

0.00 (0.00%)

Equity Financing / Related, Initial Public Offerings

Inhibikase Therapeutics, Inc. Announces Pricing Of Its Initial Public Offering

Published: 12/22/2020 23:33 GMT

IQT

(IQT) - Inhibikase Therapeutics, Inc. Announces Pricing of Its Initial Public Offering.
Inhibikase Therapeutics - Pricing of Its Ipo of 1.8 Million Shares at $10.00 per Share.